Related Experiment Video

Updated: Aug 6, 2026

Measurement of Tumor T2* Relaxation Times after Iron Oxide Nanoparticle Administration
05:30

Measurement of Tumor T2* Relaxation Times after Iron Oxide Nanoparticle Administration

Published on: May 19, 2023

T2* Magnetic Resonance Imaging Uncovers Hemosiderin Burden in Pediatric Hemophilia: A Call for Sensitive Imaging

Jessica Garcia1,2, Tarique Hussain2,3,4, Jeanne Dillenbeck2,4

  • 1Department of Pediatrics, Division of Hematology and Oncology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

Pediatric Blood & Cancer
|July 24, 2026
PubMed

Insights

T2* MRI detects hidden joint damage in children with hemophilia, even with low bleeding rates. This imaging technique shows potential for early, personalized interventions in pediatric hemophilia care.

Area of Science:

  • Orthopedics
  • Radiology
  • Pediatric Hematology

Background:

  • Hemophilic arthropathy is a major cause of morbidity in hemophilia patients.
  • Early joint damage can be missed by routine physical examinations.
  • Hemosiderin deposition is a key indicator of joint damage in hemophilia.

Purpose of the Study:

  • To explore T2* MRI as a noninvasive biomarker for hemosiderin deposition.
  • To assess the utility of T2* MRI in detecting early joint damage in pediatric hemophilia.
  • To evaluate T2* MRI's potential for personalized intervention strategies.

Main Methods:

  • Four children with severe hemophilia A or moderate-to-severe hemophilia B were included.
  • T2* MRI scans were performed in patients with persistent joint symptoms.
  • T2* relaxation times were measured and correlated with structural joint pathology.

Main Results:

  • One patient showed shortened T2* relaxation (9 ms) with identified structural joint pathology.
  • Three patients exhibited higher T2* values (22-26 ms) without detectable structural pathology.
  • T2* MRI identified occult joint damage despite low bleeding rates and joint scores.

Conclusions:

  • T2* MRI is a promising noninvasive biomarker for hemosiderin deposition in pediatric hemophilia.
  • This imaging modality can detect subclinical joint damage missed by conventional assessments.
  • T2* MRI supports early, personalized interventions for pediatric hemophilia patients globally.

Related Concept Videos

Magnetic Resonance Imaging01:24

Magnetic Resonance Imaging

Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...